The short version of Cardarine fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-25 and is reviewed periodically as new material appears.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
On 26 August 2008, Financial Times wrote that "Most accounts agree that it was South Ossetian separatists who committed the first act of escalation when they blew up a Georgian military vehicle on August 1, wounding five Georgian peacekeeping troops." It argued: "So swift was the Russian reaction that some analysts believe that, while it did not appear to precede the Georgian assault on Tskhinvali, as Mr Saakashvili claims, it may have been planned in advance, with Mr Saakashvili simply falling into a well prepared Russian trap."
=== Sources for human stem cells === Most stem cells intended for regenerative therapy are generally isolated either from the patient's bone marrow or from adipose tissue. Mesenchymal stem cells can differentiate into the cells that make up bone, cartilage, tendons, and ligaments, as well as muscle, neural and other progenitor tissues. They have been the main type of stem cells studied in the treatment of diseases affecting these tissues. The number of stem cells transplanted into damaged tissue may alter the efficacy of treatment. Accordingly, stem cells derived from bone marrow aspirates, for instance, are cultured in specialized laboratories for expansion to millions of cells. Although adipose-derived tissue also requires processing prior to use, the culturing methodology for adipose-derived stem cells is not as extensive as that for bone marrow-derived cells. While it is thought that bone-marrow-derived stem cells are preferred for bone, cartilage, ligament, and tendon repair, others believe that the less challenging collection techniques and the multi-cellular microenvironment already present in adipose-derived stem cell fractions make the latter the preferred source for autologous transplantation. New sources of mesenchymal stem cells are being researched, including stem cells present in the skin and dermis which are of interest because of the ease at which they can be harvested with minimal risk to the animal.
=== Gut microbiota unaccustomed to endemic organisms === Foodborne illness often occurs as travelers' diarrhea in persons whose gut microbiota is unaccustomed to organisms endemic to the visited region. This effect of microbiologic naïveté is compounded by any food safety lapses in the food's preparation. Locals develop immunity to local food pathogens through repeated exposure, explaining why they often don't get sick from food that affects travelers. This immune adaptation involves developing specific defenses against common local bacteria, viruses, and parasites. Through this process, locals' immune systems produce a measured response that eliminates pathogens without triggering excessive inflammatory reactions, while travelers' immune systems often mount exaggerated responses to novel pathogens.
Sources: en.wikipedia.org
=== Mass analyzer === Depending on the SIMS type, there are three basic analyzers available: sector, quadrupole, and time-of-flight. A sector field mass spectrometer uses a combination of an electrostatic analyzer and a magnetic analyzer to separate the secondary ions by their mass-to-charge ratio. A quadrupole mass analyzer separates the masses by resonant electric fields, which allow only the selected masses to pass through. The time-of-flight mass analyzer separates the ions in a field-free drift path according to their velocity. Since all ions possess the same kinetic energy the velocity and therefore time of flight varies according to mass. It requires pulsed secondary-ion generation using either a pulsed primary ion gun or a pulsed secondary-ion extraction. It is the only analyzer type able to detect all generated secondary ions simultaneously, and is the standard analyzer for static SIMS instruments.
== History == Flagler Global Logistics can trace its roots back to the original railroad and land development company founded by pioneering American businessman Henry M. Flagler in 1892. Flagler, who helped found Standard Oil, saw Florida's tourism potential and built a network of rail lines, depots, and associated infrastructure that eventually extended all the way from Jacksonville to Key West. As Florida's east coast was still lightly settled, Flagler was able to obtain wide swaths of land up and down the coast, including large tracts of property in what became Miami. After a long bankruptcy that began in 1931, Florida East Coast Railway was purchased by the Alfred I. duPont Testamentary Trust and operated as part of the St. Joe Company. In 1983, St. Joe's incorporated FOXX Holdings, which became the parent company of both Florida East Coast Railway and the railroad's new real estate arm, Flagler Development Company. FOXX was renamed Florida East Coast Industries in April 2000. In 2007, Florida East Coast Industries was purchased by Fortress Investment for $3.5 billion, and shortly afterwards, Florida East Coast Railway was spun off into a separate and distinct company from Florida East Coast Industries. To better take advantage of its strategic land holdings, and provide scalable third-party logistics, Florida East Coast Industries established South Florida Logistics Services as an LLC in Delaware in April 2013. The company officially incorporated in the state of Florida in May 2013.
== Production == On September 2, 2021, BET+ renewed the series for a second season which premiered on August 11, 2022. On July 6, 2022, BET+ renewed the series for a third season, which premiered on February 23, 2023. On May 30, 2023, BET+ renewed the series for a fourth season, which premiered on May 23, 2024. On October 31, 2024, BET+ renewed the series for a fifth season, which premiered on January 7, 2026. On March 26, 2026, the series was renewed for a sixth season, which will move to Paramount+ after the shutdown of BET+.
She was active in that role for over ten years. During that time she was also elected into the Association of American Physicians. In 2015 Dr. Huttenlocher was inducted as a Member of the National Academy of Medicine "for her pioneering studies of cell migration and alterations of cell migration in human diseases." In 2017, Huttenlocher was awarded a UW2020 grant to support her project "Engineering leukocytes generated from human iPS cells to treat human disease." At the same time, she was also elected a Fellow of the American Society for Cell Biology. In May 2020, Huttenlocher was named the Anna Ruth Brummett Professor of Pediatrics and Medical Microbiology and Immunology Chair in honor of her "major contributions to the advancement of knowledge." The following year, she was part of a large team of researchers from the University of Wisconsin Carbone Cancer Center recognized with the Society for the Immunotherapy of Cancer’s Team Science Award for "long-standing contribution to the field of cancer immunotherapy over the past 35 years." Huttenlocher's recent research projects include "Cell migration and wound repair" and "Imaging immunometabolism in live animals during host defense." In 2023, Huttenlocher published the book "From Loss to Memory: Behind the Discovery of Synaptic Pruning". It describes the discovery of synaptic pruning and its current relevance to early learning, autism, schizophrenia and Alzheimer's disease.
Sources: en.wikipedia.org
Atmosphere of the Sun: in detectable trace amounts Atmosphere of Mercury: 3.4%, and large amounts of water in Mercury's exosphere Atmosphere of Venus: 0.002% Earth's atmosphere: ≈0.40% over full atmosphere, typically 1–4% at surface Atmosphere of the Moon: in trace amounts Atmosphere of Mars: 0.03% Atmosphere of Ceres Atmosphere of Jupiter: 0.0004% – in ices only; and that of its moon Europa Atmosphere of Saturn – in ices only; Enceladus: 91% and Dione (subsurface ocean) Atmosphere of Uranus – in trace amounts below 50 bar Atmosphere of Neptune – found in the deeper layers Extrasolar planet atmospheres: including those of HD 189733 b and HD 209458 b, Tau Boötis b, HAT-P-11b, XO-1b, WASP-12b, WASP-17b, and WASP-19b. Stellar atmospheres: not limited to cooler stars and even detected in giant hot stars such as Betelgeuse, Mu Cephei, Antares and Arcturus. Circumstellar disks: including those of more than half of T Tauri stars such as AA Tauri as well as TW Hydrae, IRC +10216 and APM 08279+5255, VY Canis Majoris and S Persei.
==== Interpretation of results ==== HOMA-IR < 2: normal insulin sensitivity HOMA-IR > 2: possible insulin resistance HOMA-IR > 2,5: probable insulin resistance HOMA-IR > 5: typical results for type 2 diabetes SPINA-GR 1,41–9,00 mol/s: normal insulin sensitivity SPINA-GR ≤ 1,40 mol/s: insulin resistance SPINA-GR < 1,35 mol/s: typical results for type 2 diabetes
The 2013 AFL season was the 117th season of the Australian Football League (AFL), the highest level senior Australian rules football competition in Australia, which was known as the Victorian Football League until 1989. The season featured eighteen clubs, ran from 22 March until 28 September, and comprised a 22-game home-and-away season followed by a finals series featuring the top eight clubs. The premiership was won by the Hawthorn Football Club for the eleventh time, after it defeated Fremantle by 15 points in the 2013 AFL Grand Final. The season was marred by a series of off-field controversies, with three clubs penalised in 2013 for separate infractions which had taken place over previous years: Essendon, following an Australian Sports Anti-Doping Authority investigation into the club's supplements program; Adelaide, after illegal payments and draft-tampering charges relating to Kurt Tippett's 2009 contract extension; and Melbourne, after an investigation into allegations that the club had intentionally lost matches towards the end of the 2009 season.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.